236 related articles for article (PubMed ID: 27283990)
1. SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate.
Nettersheim D; Heimsoeth A; Jostes S; Schneider S; Fellermeyer M; Hofmann A; Schorle H
Oncotarget; 2016 Jul; 7(30):47095-47110. PubMed ID: 27283990
[TBL] [Abstract][Full Text] [Related]
2. BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma.
Nettersheim D; Jostes S; Sharma R; Schneider S; Hofmann A; Ferreira HJ; Hoffmann P; Kristiansen G; Esteller MB; Schorle H
PLoS Genet; 2015 Jul; 11(7):e1005415. PubMed ID: 26226633
[TBL] [Abstract][Full Text] [Related]
3. Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
Jostes SV; Fellermeyer M; Arévalo L; Merges GE; Kristiansen G; Nettersheim D; Schorle H
Int J Cancer; 2020 Mar; 146(6):1592-1605. PubMed ID: 31583686
[TBL] [Abstract][Full Text] [Related]
4. TCam-2 Cells Deficient for SOX2 and FOXA2 Are Blocked in Differentiation and Maintain a Seminoma-Like Cell Fate In Vivo.
Nettersheim D; Vadder S; Jostes S; Heimsoeth A; Schorle H
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31130628
[TBL] [Abstract][Full Text] [Related]
5. The plasticity of germ cell cancers and its dependence on the cellular microenvironment.
Nettersheim D; Schorle H
J Cell Mol Med; 2017 Aug; 21(8):1463-1467. PubMed ID: 28244655
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cells.
Nettersheim D; Westernströer B; Haas N; Leinhaas A; Brüstle O; Schlatt S; Schorle H
Genes Chromosomes Cancer; 2012 Jul; 51(7):717-26. PubMed ID: 22489004
[TBL] [Abstract][Full Text] [Related]
7. SOX2 and PRAME in the "reprogramming" of seminoma cells.
Orsatti A; Sirolli M; Ambrosi F; Franceschini T; Giunchi F; Franchini E; Grillini M; Massari F; Mollica V; Bianchi FM; Colecchia M; Fiorentino M; Ricci C
Pathol Res Pract; 2022 Sep; 237():154044. PubMed ID: 35930824
[TBL] [Abstract][Full Text] [Related]
8. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
[TBL] [Abstract][Full Text] [Related]
9. The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
Nettersheim D; Gillis A; Biermann K; Looijenga LH; Schorle H
Genes Chromosomes Cancer; 2011 Dec; 50(12):1033-42. PubMed ID: 21987446
[TBL] [Abstract][Full Text] [Related]
10. Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines.
Eini R; Stoop H; Gillis AJ; Biermann K; Dorssers LC; Looijenga LH
PLoS One; 2014; 9(1):e83585. PubMed ID: 24404135
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
Nonaka D
Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
[TBL] [Abstract][Full Text] [Related]
12. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of SOX2 inhibition for embryonal carcinoma.
Ushida H; Chano T; Minami K; Kita H; Kawakami T; Okabe H; Okada Y; Okamoto K
J Urol; 2012 May; 187(5):1876-81. PubMed ID: 22425046
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1, EGF and FGF4 synergistically induce differentiation of the seminoma cell line TCam-2 into a cell type resembling mixed non-seminoma.
Nettersheim D; Gillis AJ; Looijenga LH; Schorle H
Int J Androl; 2011 Aug; 34(4 Pt 2):e189-203. PubMed ID: 21649665
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications.
de Jong J; Stoop H; Gillis AJ; van Gurp RJ; van de Geijn GJ; Boer Md; Hersmus R; Saunders PT; Anderson RA; Oosterhuis JW; Looijenga LH
J Pathol; 2008 May; 215(1):21-30. PubMed ID: 18348160
[TBL] [Abstract][Full Text] [Related]
16. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
Santagata S; Ligon KL; Hornick JL
Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
[TBL] [Abstract][Full Text] [Related]
17. Mechanism and Role of SOX2 Repression in Seminoma: Relevance to Human Germline Specification.
Kushwaha R; Jagadish N; Kustagi M; Mendiratta G; Seandel M; Soni R; Korkola JE; Thodima V; Califano A; Bosl GJ; Chaganti RSK
Stem Cell Reports; 2016 May; 6(5):772-783. PubMed ID: 27132888
[TBL] [Abstract][Full Text] [Related]
18. Expression of embryonic stem cell markers in cultured JKT-1, a cell line derived from a human seminoma.
Bouskine A; Vega A; Nebout M; Benahmed M; Fénichel P
Int J Androl; 2010 Feb; 33(1):54-63. PubMed ID: 19226408
[TBL] [Abstract][Full Text] [Related]
19. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
20. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
Bode PK; Barghorn A; Fritzsche FR; Riener MO; Kristiansen G; Knuth A; Moch H
Mod Pathol; 2011 Jun; 24(6):829-35. PubMed ID: 21780320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
